| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
TRAW
Traws Pharma
|
Jun 18, 2026 | HOLD |
Buy
+3604.6% avg upside
10 analysts
|
$1.00
17.62% Upside
|
· |
|
CNTB
Connect Biopharma Holdings
|
Jun 18, 2026 | BUY |
Strong Buy
+226.3% avg upside
11 analysts
|
$7.00
250.05% Upside
|
· |
|
OMER
Omeros
|
Jun 10, 2026 | BUY |
Buy
+111.2% avg upside
14 analysts
|
$40.00
289.12% Upside
|
-5.5% |
|
ZVRA
Zevra Therapeutics
|
Jun 09, 2026 | BUY |
Strong Buy
+85.3% avg upside
15 analysts
|
$26.00
101.52% Upside
|
-7.7% |
|
HRTX
Heron Therapeutics
|
Jun 08, 2026 | BUY |
Strong Buy
+6404.5% avg upside
21 analysts
|
$2.00
379.10% Upside
|
· |
|
TLPH
Talphera
|
Jun 05, 2026 | BUY |
Buy
+332.4% avg upside
15 analysts
|
$3.00
175.24% Upside
|
· |
|
RNTX
Rein Therapeutics
|
Jun 01, 2026 | BUY |
Strong Buy
+1064.9% avg upside
5 analysts
|
$8.00
773.62% Upside
|
· |
|
RANI
Rani Therapeutics Holdings
|
Jun 01, 2026 | BUY |
Strong Buy
+1114.2% avg upside
10 analysts
|
$11.00
1305.95% Upside
|
· |
|
MNKD
MannKind
|
Jun 01, 2026 | BUY |
Buy
+78.6% avg upside
22 analysts
|
$10.00
153.74% Upside
|
· |
|
SGMT
Sagimet Biosciences, Inc. Class A
|
May 26, 2026 | BUY |
Strong Buy
+317.2% avg upside
15 analysts
|
$29.00
334.06% Upside
|
· |
|
VALN
Valneva
|
May 26, 2026 | BUY |
Strong Buy
+107.4% avg upside
5 analysts
|
$18.00
234.62% Upside
|
· |
|
TSE:CRDL
Cardiol Therapeutics
|
May 26, 2026 | BUY |
Strong Buy
+634.8% avg upside
6 analysts
|
$12.73
748.71% Upside
|
· |
|
MIST
Milestone Pharmaceuticals
|
May 26, 2026 | BUY |
Strong Buy
+537.4% avg upside
7 analysts
|
$8.00
515.44% Upside
|
-7.1% |
|
SINT
Sintx Technologies
|
May 20, 2026 | BUY |
Buy
+283.3% avg upside
8 analysts
|
$10.00
373.88% Upside
|
-0.4% |
|
CRMD
Cormedix
|
May 15, 2026 | BUY |
Strong Buy
+73.5% avg upside
13 analysts
|
$13.00
49.95% Upside
|
+13.1% |
|
PTHS
Pelthos Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+95.7% avg upside
8 analysts
|
$60.00
106.84% Upside
|
-3.4% |
|
PYPD
PolyPid
|
May 14, 2026 | BUY |
Strong Buy
+248.1% avg upside
7 analysts
|
$13.00
174.25% Upside
|
+7.8% |
|
DERM
Journey Medical Corp
|
May 14, 2026 | BUY |
Strong Buy
+98.3% avg upside
11 analysts
|
$13.00
109.10% Upside
|
-6.8% |
|
TSE:EPRX
Eupraxia Pharmaceuticals
|
May 14, 2026 | BUY |
Strong Buy
+147.7% avg upside
8 analysts
|
$15.56
71.86% Upside
|
· |
|
ENTA
Enanta Pharmaceuticals
|
May 12, 2026 | BUY |
Buy
+159.2% avg upside
17 analysts
|
$20.00
58.04% Upside
|
-13.0% |
|
ACHV
Achieve Life Sciences
|
May 12, 2026 | BUY |
Strong Buy
+211.2% avg upside
12 analysts
|
$12.00
147.48% Upside
|
-10.5% |
|
XERS
Xeris Pharmaceuticals
|
May 08, 2026 | BUY |
Strong Buy
+33.6% avg upside
10 analysts
|
$10.00
43.88% Upside
|
+5.7% |
|
ANIP
ANI Pharmaceuticals
|
May 08, 2026 | BUY |
Strong Buy
+28.7% avg upside
11 analysts
|
$121.00
52.29% Upside
|
· |
|
COLL
Collegium Pharmaceutical
|
May 08, 2026 | BUY |
Strong Buy
+25.7% avg upside
8 analysts
|
$60.00
78.94% Upside
|
-10.6% |
|
TRVI
Trevi Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+17.4% avg upside
16 analysts
|
$21.00
21.93% Upside
|
-2.1% |
|
INDV
Indivior
|
May 01, 2026 | BUY |
Strong Buy
+2.1% avg upside
9 analysts
|
$48.00
25.41% Upside
|
+0.7% |
|
ADIL
Adial Pharmaceuticals
|
Mar 04, 2025 | BUY |
Strong Buy
+1855.2% avg upside
6 analysts
|
$200.00
7592.34% Upside
|
-87.6% |
|
RMTI
Rockwell Med
|
Nov 14, 2024 | BUY |
Buy
+1445.2% avg upside
11 analysts
|
$5.00
681.28% Upside
|
-69.5% |
|
EBS
Emergent Biosolutions
|
Aug 22, 2024 | BUY |
Buy
+216.6% avg upside
9 analysts
|
$16.00
100.02% Upside
|
-15.8% |
|
CERS
Cerus
|
May 03, 2024 | BUY |
Strong Buy
+99.1% avg upside
10 analysts
|
$4.00
48.10% Upside
|
+67.9% |
|
ELUT
Elutia
|
May 12, 2023 | BUY |
Strong Buy
+664.1% avg upside
5 analysts
|
$10.00
843.46% Upside
|
-21.6% |
|
OBSEF
ObsEva
|
Mar 17, 2023 | HOLD |
Buy
+10799900.0% avg upside
8 analysts
|
— | · |
|
IMVIF
IMV
|
Mar 17, 2023 | HOLD |
Buy
+2444773950.1% avg upside
7 analysts
|
— | · |
|
EGRX
Eagle Pharmaceuticals
|
Mar 13, 2023 | HOLD |
Sell
+3965.0% avg upside
2 analysts
|
$33.00
5265.81% Upside
|
-94.9% |
|
VERU
Veru
|
Feb 09, 2023 | BUY |
Strong Buy
+568.5% avg upside
10 analysts
|
$15.00
408.54% Upside
|
-85.9% |
|
R
Ryder System
|
Feb 03, 2023 | BUY |
Strong Buy
-22.4% avg upside
14 analysts
|
$48.00
81.84% Downside
|
+67.7% |
|
RDHL
RedHill Biopharma
|
Nov 22, 2022 | BUY |
Strong Buy
+2357.6% avg upside
7 analysts
|
$40.00
4815.29% Upside
|
-98.4% |
|
SRNE
Sorrento Therapeutics
|
Nov 02, 2022 | BUY |
Strong Buy
+2272627.3% avg upside
7 analysts
|
$5.00
454445.53% Upside
|
· |
|
TRVN
Trevena
|
Mar 31, 2022 | BUY |
Buy
+128278.4% avg upside
11 analysts
|
$50.00
450350.40% Upside
|
· |
|
ALKS
Alkermes
|
Jan 27, 2022 | BUY |
Strong Buy
-17.6% avg upside
34 analysts
|
$32.00
28.97% Downside
|
+13.0% |
|
AXGN
AxoGen
|
Nov 04, 2021 | BUY |
Strong Buy
-25.7% avg upside
21 analysts
|
$25.00
44.28% Downside
|
-69.4% |
|
JAZZ
Jazz Pharmaceuticals
|
Oct 06, 2021 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
$210.00
6.59% Downside
|
-5.8% |
|
VRAYQ
Viewray
|
Aug 09, 2021 | BUY |
Strong Buy
+558333233.4% avg upside
12 analysts
|
$8.00
799999900.07% Upside
|
-99.8% |
|
SMTI
Sanara MedTech
|
Jun 30, 2021 | BUY |
Strong Buy
+76.2% avg upside
5 analysts
|
$45.00
104.33% Upside
|
+8.5% |
|
SIBN
SI-Bone
|
Dec 15, 2020 | BUY |
Strong Buy
+60.4% avg upside
18 analysts
|
$33.00
108.38% Upside
|
-54.2% |
|
PAHC
Phibro Animal Health
|
Sep 12, 2016 | BUY |
Hold
+17.0% avg upside
10 analysts
|
$30.00
5.72% Downside
|
+73.1% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.